Profusa, Inc. (PFSA) has taken a significant step toward commercializing its biosensor technology with the launch of its Lumee tissue-oxygen healthcare and research offerings, a move that also initiates the company's first commercial revenue.
Research-use-only offerings are commercially available, enabling immediate product and service revenue generation. The launch also targets the global contract research organization…
